Antioxidant Therapy in RYR1-Related Congenital Myopathy

NCT02362425 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

63

Enrollment

NIH

Sponsor class

Conditions

Neuromuscular Disease

Interventions

DRUG: N-acetylcysteine
DRUG: Placebo

Sponsor

National Institute of Nursing Research (NINR)